How a Drug Company Made $114 Billion by Gaming the U.S. Pate

AbbVie for years delayed competition for its blockbuster drug Humira, at the expense of patients and taxpayers. The monopoly is about to end.

Related Keywords

New York , United States , Ohio , Brook Park , Washington , Crestwood , District Of Columbia , Bahamas , The , Amgen Amjevita , Melissa Andersen , Richard Gonzalez , Jessica Akopyan , Bill Chase , Rachel Sachs , Initiative For Medicines , Amgen , Pfizer , Astrazeneca , New York Times , Bristol Myers Squibb , Washington University In St , Barb Teron , Nic Antaya , Washington University , Affordable Care Act , Inventions And Patents , Pharmaceuticals Prescription Drugs , Price , Lawsuits , Humira , Competition Law , Intellectual Property , ,